Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.
Bernhard J, Zahrieh D, Zhang JJ, Martinelli G, Basser R, Hürny C, Forbes JF, Aebi S, Yeo W, Thürlimann B, Green MD, Colleoni M, Gelber RD, Castiglione-Gertsch M, Price KN, Goldhirsch A, Coates AS; International Breast Cancer Study Group.
Bernhard J, et al. Among authors: colleoni m.
Br J Cancer. 2008 Jan 15;98(1):25-33. doi: 10.1038/sj.bjc.6604092. Epub 2007 Nov 27.
Br J Cancer. 2008.
PMID: 18043579
Free PMC article.
Clinical Trial.